依达拉奉治疗血管源性帕金森综合征的临床分析

来源 :中国卫生标准管理 | 被引量 : 0次 | 上传用户:CoolSky_BO
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探究依达拉奉治疗血管源性帕金森综合征的效果。方法将血管源性帕金森综合征患者64例随机分为两组,对照组采用常规治疗,治疗组采用依达拉奉联合常规治疗。结果治疗组患者治疗总有效率高于对照组(P<0.05),患者精神、行为和情绪评分低于对照组(P<0.05)。结论血管源性帕金森综合征采用依达拉奉治疗,可有效改善患者精神和情绪症状,治疗效果良好。 Objective To investigate the efficacy of edaravone in the treatment of vascular parkinsonism. Methods Sixty-four patients with vascular-parkinsonism were randomly divided into two groups. The control group was treated with conventional therapy. The treatment group was treated with edaravone combined with conventional therapy. Results The total effective rate of treatment group was higher than that of control group (P <0.05). The score of mental, behavior and emotion of the treatment group was lower than that of the control group (P <0.05). Conclusion Edaravone treatment of vasogenic parkinsonism can effectively improve the mental and emotional symptoms of patients, and the treatment effect is good.
其他文献
ue*M#’#dkB4##8#”专利申请号:00109“7公开号:1278062申请日:00.06.23公开日:00.12.27申请人地址:(100084川C京市海淀区清华园申请人:清华大学发明人:隋森芳文摘:本发明属于生物技
目的:研究分析腰椎管狭窄患者接受显微微创治疗的效果。方法2011年~2014年我院选取了150例腰椎管狭窄患者来进行研究分析,将这些患者分组为对照组和微创组,每组均有75例,对照组患